Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005015953> ?p ?o ?g. }
- W2005015953 endingPage "527" @default.
- W2005015953 startingPage "521" @default.
- W2005015953 abstract "The stimulatory effect of exogenous bombesin and its related mammalian peptides on gastric acid secretion and gastrin release has been examined in detail, while the regulatory role of endogenously released bombesin-like peptides is largely unknown. Accordingly we have determined the effect of a specific bombesin receptor antagonist during vagal stimulation of gastric acid secretion and gastrin release. In anesthetized rats electrical stimulation of the vagal nerves (10 V, 10 Hz, 1 ms) significantly increased plasma gastrin levels by 82 ± 11 pg/20 min (P < 0.01) and gastric acid output by 99.4 ± 9.9 μeq/20 min (P < 0.01). Intravenous infusion of the specific bombesin receptor antagonist d-Phe6-BN(6–13)OMe (400 nmol/kg/h) significantly reduced vagally induced increase of plasma gastrin levels by 70% to 29 ± 8 pg/20 min (P < 0.05 vs control) and vagally stimulated gastric acid output by 40% to 57.4 ± 10.6 μeq/20 min (P < 0.05 vs control). To demonstrate that the residual gastrin and acid response is due to non-bombesinergic mechanisms and not to an inadequate dose of the receptor antagonist, the latter was tested against gastrin-releasing peptide (GRP) at the maximally effective concentration of 300 pmol/kg/h, which resulted in an even 50% higher increase of plasma gastrin levels compared to vagal stimulation. The dose of the antagonist employed (400 nmol/kg/h) was sufficient to abolish GRP-induced stimulation of gastrin and gastric acid secretion. Previously it has been postulated that endogenous bombesin-peptides can stimulate acid secretion via gastrin-independent mechanisms. To investigate this possibility further the effect of the antagonist was examined on vagally induced acid secretion while gastrin levels were restored to the range of the respective control experiments. In presence of the antagonist the infusion of gastrin-17 (15 pmol/kg/h) in addition to vagal stimulation elevated plasma gastrin to levels not different from those during vagal stimulation alone. With identical plasma gastrin levels the bombesin receptor antagonist had no effect on vagally stimulated acid secretion (86.3 ± 10.7 μeq/20 min vs 99.4 ± 9.9 μeq/20 min in the controls; n.s.). In conclusion, the present data demonstrate for the first time that in rats in vivo endogenous bombesin peptides contribute to vagal stimulation of gastrin release and gastric acid secretion. Furthermore, endogenous bombesin-peptides exert their action on parietal cell function via an increase of gastrin release, while non-gastrinergic mechanisms are unimportant under the experimental conditions employed." @default.
- W2005015953 created "2016-06-24" @default.
- W2005015953 creator A5005645866 @default.
- W2005015953 creator A5021831733 @default.
- W2005015953 creator A5030737243 @default.
- W2005015953 creator A5033411437 @default.
- W2005015953 creator A5074790681 @default.
- W2005015953 creator A5091899058 @default.
- W2005015953 date "1996-12-01" @default.
- W2005015953 modified "2023-09-25" @default.
- W2005015953 title "Role of endogenous bombesin-peptides during vagal stimulation of gastric acid secretion in the rat" @default.
- W2005015953 cites W1531894043 @default.
- W2005015953 cites W1549512689 @default.
- W2005015953 cites W1607867087 @default.
- W2005015953 cites W1822950385 @default.
- W2005015953 cites W1963542790 @default.
- W2005015953 cites W1963962978 @default.
- W2005015953 cites W1971583390 @default.
- W2005015953 cites W1974730933 @default.
- W2005015953 cites W1977410353 @default.
- W2005015953 cites W1979034807 @default.
- W2005015953 cites W2001501517 @default.
- W2005015953 cites W2012603088 @default.
- W2005015953 cites W2014186086 @default.
- W2005015953 cites W2025572460 @default.
- W2005015953 cites W2031085889 @default.
- W2005015953 cites W2032072810 @default.
- W2005015953 cites W2033479245 @default.
- W2005015953 cites W2038000885 @default.
- W2005015953 cites W2038396811 @default.
- W2005015953 cites W2043178576 @default.
- W2005015953 cites W2045536644 @default.
- W2005015953 cites W2049193090 @default.
- W2005015953 cites W2062098928 @default.
- W2005015953 cites W2063506585 @default.
- W2005015953 cites W2064552381 @default.
- W2005015953 cites W2065571239 @default.
- W2005015953 cites W2071789617 @default.
- W2005015953 cites W2072326775 @default.
- W2005015953 cites W2077564591 @default.
- W2005015953 cites W2085733340 @default.
- W2005015953 cites W2417041523 @default.
- W2005015953 cites W246657860 @default.
- W2005015953 cites W2767402534 @default.
- W2005015953 cites W317382823 @default.
- W2005015953 cites W4238966243 @default.
- W2005015953 cites W4323284734 @default.
- W2005015953 cites W2063184672 @default.
- W2005015953 doi "https://doi.org/10.1016/s0143-4179(96)90033-5" @default.
- W2005015953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9004248" @default.
- W2005015953 hasPublicationYear "1996" @default.
- W2005015953 type Work @default.
- W2005015953 sameAs 2005015953 @default.
- W2005015953 citedByCount "7" @default.
- W2005015953 countsByYear W20050159532013 @default.
- W2005015953 countsByYear W20050159532016 @default.
- W2005015953 countsByYear W20050159532018 @default.
- W2005015953 crossrefType "journal-article" @default.
- W2005015953 hasAuthorship W2005015953A5005645866 @default.
- W2005015953 hasAuthorship W2005015953A5021831733 @default.
- W2005015953 hasAuthorship W2005015953A5030737243 @default.
- W2005015953 hasAuthorship W2005015953A5033411437 @default.
- W2005015953 hasAuthorship W2005015953A5074790681 @default.
- W2005015953 hasAuthorship W2005015953A5091899058 @default.
- W2005015953 hasConcept C118303440 @default.
- W2005015953 hasConcept C126322002 @default.
- W2005015953 hasConcept C134018914 @default.
- W2005015953 hasConcept C16613235 @default.
- W2005015953 hasConcept C170493617 @default.
- W2005015953 hasConcept C185592680 @default.
- W2005015953 hasConcept C24998067 @default.
- W2005015953 hasConcept C2776885963 @default.
- W2005015953 hasConcept C2776986829 @default.
- W2005015953 hasConcept C2776998989 @default.
- W2005015953 hasConcept C2777504413 @default.
- W2005015953 hasConcept C2777951760 @default.
- W2005015953 hasConcept C2778122271 @default.
- W2005015953 hasConcept C2778448772 @default.
- W2005015953 hasConcept C49039625 @default.
- W2005015953 hasConcept C56191518 @default.
- W2005015953 hasConcept C71924100 @default.
- W2005015953 hasConcept C86803240 @default.
- W2005015953 hasConceptScore W2005015953C118303440 @default.
- W2005015953 hasConceptScore W2005015953C126322002 @default.
- W2005015953 hasConceptScore W2005015953C134018914 @default.
- W2005015953 hasConceptScore W2005015953C16613235 @default.
- W2005015953 hasConceptScore W2005015953C170493617 @default.
- W2005015953 hasConceptScore W2005015953C185592680 @default.
- W2005015953 hasConceptScore W2005015953C24998067 @default.
- W2005015953 hasConceptScore W2005015953C2776885963 @default.
- W2005015953 hasConceptScore W2005015953C2776986829 @default.
- W2005015953 hasConceptScore W2005015953C2776998989 @default.
- W2005015953 hasConceptScore W2005015953C2777504413 @default.
- W2005015953 hasConceptScore W2005015953C2777951760 @default.
- W2005015953 hasConceptScore W2005015953C2778122271 @default.
- W2005015953 hasConceptScore W2005015953C2778448772 @default.
- W2005015953 hasConceptScore W2005015953C49039625 @default.
- W2005015953 hasConceptScore W2005015953C56191518 @default.